crohn's and glp 1 In a patient with moderate disease, is it safe to start a GLP‑1 receptor agonist, what dosing and monitoring steps are recommended? glp-1 and crohn's disease Adjunctive

INGREDIENTS RESOURCES

nAMD Symptoms May Include: Distortion of straight lines (metamorphopsia) Blurred or fuzzy central vision Dark or empty areas in the center of vision Difficulty seeing fine detail, even with glasses Sudden worsening of visual acuity The aggressive nature of nAMD means early detection plays a key role in preventing permanent vision loss

Physiol Rev 87:245313 Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development

438 Similarly, sequencing of estrogen pathway-related genes in CTCs revealed resistance mutations distinct from those in the primary tumor, underscoring their value in guiding endocrine therapy